Sanofi and Regeneron have teamed up with a Broadway actor to promote the launch of JoinLungZone.com.
The online program features Broadway actor and reality TV star Tommy Bracco, who has battled severe asthma since childhood. Bracco credits a treatment plan centered on Dupixent as being a stabilizing force while living with asthma, which previously resulted in numerous hospitalizations.
“All of this work I was putting in to manage my symptoms — all of my tips and tricks… that’s when I realized this shouldn’t be ‘normal,” he said in a video on the campaign site. “I realized I needed to do more for my lung health. After what I’ve gone through, I feel a responsibility to help others feel less alone.”
Through the initiative, Bracco is sharing his story on social media and the campaign website in an effort to encourage patients living with uncontrolled moderate-to-severe asthma to ask their doctor about Dupixent. Approximately 25 million Americans have asthma, according to data from the Centers for Disease Control and Prevention.
JoinLungZone.com also features video tutorials for asthma patients from health experts, including a personal trainer as well as a mindset coach and meditation instructor.
The launch of the website marks the latest initiative to promote Dupixent as a treatment option for addressing asthma attacks.
Late last month, the drug received approval from the Food and Drug Administration for treatment indicated for prurigo nodularis, a chronic skin disease. In May, the FDA approved Dupixent as treatment for eosinophilic esophagitis in adults and children over the age of 12.Additionally, both Sanofi and Regeneron are expected to release their latest financial reports in the coming weeks. Sanofi will release its earnings on October 28 and Regeneron will release its earnings on November 3.